Drug
Ularitide clinical trials
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2003 (1)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2012 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 2
Cardiorentis (1) · Rocky Mountain Cancer Centers (1) · University of Aarhus (1) · Facet Biotech (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Bronchodilator Agents source
- One of Diuretics source
Studies
Open first, then newest update. How each study uses Ularitide is read from its arms, and is right about nine times in ten.
Testing it · 4
- Refractory Ascites in Patients With Liver Cirrhosis, and the Potential Treatment With 48 Hours Infusion of Ularitide.TerminatedPhase 2University of AarhusNCT04311489Written as Ularitide
- Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart FailureCompletedPhase 3CardiorentisNCT01661634Written as Ularitide
- A Study of Ularitide in the Treatment of Subjects With Acute Decompensated Heart FailureWithdrawnPhase 1Facet BiotechNCT00487799Written as Ularitide
- Prevention Of Nephrotoxicity Following Bone Marrow Transplantation Using Urodilatin and MannitolCompletedPhase 2Rocky Mountain Cancer CentersNCT00390624Written as URODILATIN (ULARITIDE, ATRIAL NATRIURETIC PEPTIDE)
Codes
What other systems call Ularitide · ClinicalTrials.gg INT003384
- MeSH (NLM) C056452UlaritideConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 740Y5J48Z8ULARITIDEConfirmed FDA, NLM
- NCI Thesaurus C96702UlaritideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C056452 | Ularitide | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 740Y5J48Z8 | ULARITIDE | Confirmed FDA, NLM |
| NCI Thesaurus | C96702 | Ularitide | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.